首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy
Authors:Christian M Hagen  Frederik H Aidt  Ole Havndrup  Paula L Hedley  Morten K Jensen  J?rgen K Kanters  Tam T Pham  Henning Bundgaard  Michael Christiansen
Institution:1. Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; 2. Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; 3. Department of Cardiology, Roskilde Hospital, Roskilde, Denmark.; 4. Department of Medicine B, The Heart Center, Rigshospitalet, Copenhagen, Denmark.; San Francisco Coordinating Center, UNITED STATES,
Abstract:Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease primarily caused by mutations in genes coding for sarcomeric proteins. A molecular-genetic etiology can be established in ~60% of cases. Evolutionarily conserved mitochondrial DNA (mtDNA) haplogroups are susceptibility factors for HCM. Several polymorphic mtDNA variants are associated with a variety of late-onset degenerative diseases and affect mitochondrial function. We examined the role of private, non-haplogroup associated, mitochondrial variants in the etiology of HCM. In 87 Danish HCM patients, full mtDNA sequencing revealed 446 variants. After elimination of 312 (69.9%) non-coding and synonymous variants, a further 109 (24.4%) with a global prevalence > 0.1%, three (0.7%) haplogroup associated and 19 (2.0%) variants with a low predicted in silico likelihood of pathogenicity, three variants: MT-TC: m.5772G>A, MT-TF: m.644A>G, and MT-CYB: m.15024G>A, p.C93Y remained. A detailed analysis of these variants indicated that none of them are likely to cause HCM. In conclusion, private mtDNA mutations are frequent, but they are rarely, if ever, associated with HCM.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号